B7-33 is an experimental peptide derived from a biologically active region of the relaxin family. It has been investigated for its interaction with relaxin-related signaling pathways and cellular responses. Research interest surrounding B7-33 includes studies of tissue remodeling, cellular signaling, vascular biology, and mechanisms associated with extracellular matrix regulation, making it a distinctive compound for advanced peptide research.